The Sherwin-Williams Company (S1HW34)
B3 Stock Exchange · Brazil · prices in BRL · close of 27 Oct 2026
Key indicators
| Last close | BRL 175.36 |
|---|---|
| 52-week range | 147.00 – 195.77 |
| Return, 1 month / 3 months | +2.4% / +11.4% |
| Return, 1 year / 3 years | −2.0% / +51.4% |
| Trend | Uptrend |
| RSI (14) | 58 |
| Volatility (1 year) | 33.7% |
| Worst drawdown (1 year) | -23.2% |
| Average daily value traded | 0.03M BRL |
| Dividend yield | 3.2% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
The Sherwin-Williams Company makes and sells paints, coatings and related supplies. Its products include architectural paints for homes and commercial buildings, plus industrial coatings for manufacturers and other businesses. The company serves professional painters, contractors, industrial customers and do-it-yourself buyers through its own paint stores and through retailers. It is based in Cleveland, Ohio, in the United States, and its paints reach customers in many countries around the world.
The Sherwin-Williams Company is represented on the B3 Stock Exchange in Brazil by a Brazilian depositary receipt (BDR) under the code S1HW34, with its price quoted in Brazilian reais (BRL). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
The Sherwin-Williams Company (S1HW34) trades on the B3 Stock Exchange in Brazil. It last closed at BRL 175.36 on 27 October 2026.
Its price-based Market X-Ray is 52 out of 100 (a fair price profile), ranking 677 of 1,455 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 2.0% and over the last three months it rose 11.4%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on B3 Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 53 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 2.4% | ||
| From 52-week high | -8.9% | ||
| Momentum | 50 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 11.4% | ||
| 6-month return | 2.3% | ||
| 12-month return, skipping the last month | -4.3% | ||
| Stability (higher is calmer) | 64 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 33.7% | ||
| Worst drawdown, 1 year (smaller is calmer) | -23.2% | ||
| Liquidity | 34 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.03M BRL | ||
| Zero-volume days | 35.0% | ||
| Income | 54 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 3.2% | ||
| Years with dividends | 6 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | +4.2% |
|---|---|
| 1 month | +2.4% |
| 3 months | +11.4% |
| 6 months | +2.3% |
| 1 year | −2.0% |
| 3 years | +51.4% |
| 5 years | +3.7% |
Signals
| 50-day / 200-day average | 171.10 / 171.30 |
|---|---|
| Golden / death cross (60 days) | Death, 0 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 3.61 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 19 Aug 2026 | USD 0.2740 |
| 20 May 2026 | USD 0.2797 |
| 26 Feb 2026 | USD 0.2849 |
| 12 Nov 2025 | USD 0.2899 |
| 13 Aug 2025 | USD 0.2900 |
| 14 May 2025 | USD 0.2979 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on B3 Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.